Quick Answer
BALCHEM CORP reported Operating Income of $209.33 million for fiscal year 2025.
BALCHEM CORP Operating Income — Annual History
| Fiscal Year | Operating Income | YoY Change |
|---|---|---|
| 2025 | $209.33M | +14.4% |
| 2024 | $182.91M | +14.9% |
| 2023 | $159.19M | +9.6% |
| 2022 | $145.19M | +13.9% |
| 2021 | $127.50M | +14.7% |
| 2020 | $111.15M | +8.4% |
| 2019 | $102.55M | -4.2% |
| 2018 | $107.10M | +10.5% |
| 2017 | $96.90M | +6.7% |
| 2016 | $90.84M | -3.3% |
| 2015 | $93.96M | +14.4% |
| 2014 | $82.14M | +25.2% |
| 2013 | $65.60M | +9.7% |
| 2012 | $59.78M | +6.3% |
| 2011 | $56.23M | +13.0% |
| 2010 | $49.77M | +22.4% |
| 2009 | $40.66M | — |
Quarterly Operating Income
| Quarter Ending | Operating Income | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $54.58M | +13.7% | +6.1% |
| June 30, 2025 | $51.44M | +12.3% | +0.8% |
| March 31, 2025 | $51.02M | +22.4% | +6.3% |
| September 30, 2024 | $47.99M | +10.0% | +4.8% |
| June 30, 2024 | $45.80M | +6.9% | +9.9% |
| March 31, 2024 | $41.68M | +21.1% | -4.4% |
| September 30, 2023 | $43.61M | +29.7% | +1.8% |
| June 30, 2023 | $42.84M | +7.3% | +24.5% |
- BALCHEM CORP showed an increase of +14.4% in Operating Income compared to the prior fiscal year.
- Over the 2009–2025 period, BALCHEM CORP’s operating income has grown by 414.8% (from $40.66 million to $209.33 million).
- The most recent figure is from BALCHEM CORP’s fiscal year 2025 report (Form 10-K), filed with the SEC on February 20, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: